锦欣生殖医疗集团有限公司（01951）于2026年4月28日发布公告，披露其当日在香港联交所场内回购普通股，数量为206.60万股，约占公司已发行股本的0.08%。本次回购价格区间介乎每股2.38港元至2.42港元，总涉资约496.07万港元。
公告显示，截至本次回购完成后，公司已发行股本总数维持在2,705,044,043股，库藏股数目仍为零。本次回购授权于2025年6月26日获股东大会通过，截至目前公司已根据该授权累计回购股份57,328,000股，占授权通过当日公司已发行股本约2.0887%。
公司同时确认，回购事宜符合香港联合交易所有限公司证券上市规则及相关法律要求。上述公告由公司董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.